Ankur Dhingra - 07 Mar 2023 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Chief Financial Officer
Signature
/s/ Ankur Dhingra
Issuer symbol
SMMT
Transactions as of
07 Mar 2023
Net transactions value
+$206,180
Form type
4
Filing time
08 Mar 2023, 16:24:11 UTC
Previous filing
08 Mar 2023
Next filing
13 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMMT Common Stock Purchase $206,180 +196,362 +514% $1.05 234,558 07 Mar 2023 By Dhingra Family Revocable Trust F1, F2
holding SMMT Common Stock 39,527 07 Mar 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering.
F2 The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.